diabetes
-
February 1, 2024
A biomarker for early Type 2 diabetes
Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures. -
January 4, 2024
Study shows liraglutide results in increased insulin sensitivity independent of weight loss
-
December 4, 2023
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. -
November 6, 2023
Powers receives prestigious Veterans Affairs Middleton Award
Alvin C. Powers, MD, Joe C. Davis Professor of Biologic Science and professor of Medicine, Molecular Physiology and Biophysics, has received the 2023 William S. Middleton Award, the highest honor awarded by the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Service. -
November 1, 2023
Pancreas “crosstalk” may influence course of Type 1 and Type 2 diabetes
In the largest study of its kind, researchers at Vanderbilt have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with aging and obesity. -
October 17, 2023
Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention
A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes. -
September 12, 2023
Dame Frances Ashcroft Discovery Lecture postponed